Chronic Disease Management DTP Pharmacy Diagram

Strengths

• AI chronic disease management enhances patient repurchase stickiness, significantly increasing the automation rate of prescription renewals
• Insurance direct billing lowers the upfront payment threshold for patients, attracting an influx of high-priced innovative drug prescriptions

Weaknesses

• HIS system integration relies on hospital cooperation, and the execution chain for prescription routing implementation is complex
• High inventory turnover costs for innovative drugs in DTP impose heavy pressure on the capital chain

Opportunities

• Continued expansion of Huiminbao and corporate supplementary medical coverage, leading to rapid growth in insurance direct billing scenarios
• Volume expansion of innovative chronic disease drugs such as GLP-1, offering substantial room for DTP pharmacies to handle high-value prescriptions

Threats

• Local lifestyle platforms such as Meituan inversely penetrating prescription routing, compressing profit margins for independent platforms
• Stricter medical insurance fund cost control, increasing price negotiation pressure for DTP pharmacies